体外二氧化碳清除控制慢性阻塞性肺疾病急性加重期无创NAVA通气患者的呼吸驱动
本研究为生理学研究,纳入20例严重COPD急性加重接受静脉-静脉体外二氧化碳清除(vv-ECCO2R)并辅以无创神经调节辅助通气(NIV-NAVA)的患者,在逐步撤除vv-ECCO2R过程中观察膈肌电活动(Edi)反应。撤机成功12例、失败8例,撤机成功组Edi为19 ± 10 μV,失败组为56 ± 20 μV,所有患者CO2和pH保持稳定。Edi是预测vv-ECCO2R撤机失败的最佳指标(ROC分析AUC 0.95),呼吸频率、快速浅呼吸指数和潮气量预测价值较低。最终19例出院回家,1例死亡,90天死亡率为15%,180天死亡率为25%。
要点
- 在COPD急性加重行NIV-NAVA通气的患者中,撤除vv-ECCO2R成功组Edi为19 ± 10 μV,失败组为56 ± 20 μV。
- Edi是预测vv-ECCO2R撤机失败的最佳指标,ROC分析AUC为0.95。
- 呼吸频率、快速浅呼吸指数和潮气量对vv-ECCO2R撤机失败的预测价值低于Edi。
- 20例患者中撤机成功12例、失败8例,撤机过程中所有患者CO2和pH值保持稳定。
- 最终19例出院回家,1例死亡;90天死亡率为15%,180天死亡率为25%。
适用人群与场景
- 20例严重急性加重期COPD患者(SAPS II 37 ± 5.6,年龄57 ± 9岁),接受vv-ECCO2R并辅以NIV-NAVA通气。
处置流程与药物剂量
- 在vv-ECCO2R逐步撤机过程中,根据呼吸困难、耐受性和血气分析判断撤机是否成功。
- 通过Edi信号监测呼吸驱动,Edi是预测vv-ECCO2R撤机失败的最佳指标(ROC分析AUC 0.95)。
研究设计与关键结果
- 研究类型:生理学研究,纳入20例严重COPD急性加重接受vv-ECCO2R和NIV-NAVA的患者,在vv-ECCO2R逐步撤机过程中观察Edi反应。
- 撤机成功12例,失败8例;撤机成功组Edi为19 ± 10 μV,失败组Edi为56 ± 20 μV,所有患者CO2和pH值保持稳定。
- Edi是预测vv-ECCO2R撤机失败的最佳指标(ROC分析AUC 0.95),呼吸频率、快速浅呼吸指数和潮气量预测价值较低。
- 最终19例出院回家,1例死亡;90天死亡率为15%,180天死亡率为25%。
证据类型、等级与局限
- 证据类型:生理学研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,Edi信号可用于监测和指导严重COPD急性加重接受vv-ECCO2R和NIV-NAVA的患者。
- 作者认为,vv-ECCO2R撤机过程中的Edi是预测患者对撤除vv-ECCO2R耐受性的最佳指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Veno-venous extracorporeal CO2 removal (vv-ECCO2R) and non-invasive neurally adjusted ventilator assist (NIV-NAVA) are two promising techniques which may prevent complications related to prolonged invasive mechanical ventilation in patients with acute exacerbation of COPD.
METHODS: A physiological study of the electrical activity of the diaphragm (Edi) response was conducted with varying degrees of extracorporeal CO2 removal to control the respiratory drive in patients with severe acute exacerbation of COPD breathing on NIV-NAVA.
RESULTS: Twenty COPD patients (SAPS II 37 ± 5.6, age 57 ± 9 years) treated with vv-ECCO2R and supported by NIV-NAVA were studied during stepwise weaning of vv-ECCO2R. Based on dyspnea, tolerance, and blood gases, weaning from vv-ECCO2R was successful in 12 and failed in eight patients. Respiratory drive (measured via the Edi) increased to 19 ± 10 μV vs. 56 ± 20 μV in the successful and unsuccessful weaning groups, respectively, resulting in all patients keeping their CO2 and pH values stable. Edi was the best predictor for vv-ECCO2R weaning failure (ROC analysis AUC 0.95), whereas respiratory rate, rapid shallow breathing index, and tidal volume had lower predictive values. Eventually, 19 patients were discharged home, while one patient died. Mortality at 90 days and 180 days was 15 and 25%, respectively.
CONCLUSIONS: This study demonstrates for the first time the usefulness of the Edi signal to monitor and guide patients with severe acute exacerbation of COPD on vv-ECCO2R and NIV-NAVA. The Edi during vv-ECCO2R weaning was found to be the best predictor of tolerance to removing vv-ECCO2R.
参考来源
- Karagiannidis C, Strassmann S, Schwarz S, et al. Control of respiratory drive by extracorporeal CO2 removal in acute exacerbation of COPD breathing on non-invasive NAVA. Crit Care. 2019. PMID: 31014366. doi:10.1186/s13054-019-2404-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。